Skip to main content

Recursion Pharmaceuticals, Inc.

RXRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001601830

In the last 90 days, Recursion Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 4 sales; 344 institutions reported holding it in 13F filings for Q2 2026, worth $1.33B in total; ARK Invest is the only superinvestor holding it.

13F holders, Q1 2022

Institutional positions in Recursion Pharmaceuticals, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
128
+3 vs. Q4 2021
Shares held
95.0M
+697.7K (+0.7%) vs. Q4 2021
Total value
$680.3M
−$936.2M (−57.9%) vs. Q4 2021
New holders
24
40 more added
Sold out
21
37 more reduced

1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RXRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2022: 128 institutions
Q1 2021: 1 institutionQ2 2021: 75 institutionsQ3 2021: 84 institutionsQ4 2021: 126 institutionsQ1 2022: 128 institutionsQ2 2022: 133 institutionsQ3 2022: 146 institutionsQ4 2022: 144 institutionsQ1 2023: 159 institutionsQ2 2023: 158 institutionsQ3 2023: 192 institutionsQ4 2023: 199 institutionsQ1 2024: 248 institutionsQ2 2024: 270 institutionsQ3 2024: 268 institutionsQ4 2024: 316 institutionsQ1 2025: 337 institutionsQ2 2025: 333 institutionsQ3 2025: 322 institutionsQ4 2025: 335 institutionsQ1 2026: 335 institutionsQ2 2026: 344 institutions
Value heldQ1 2022: $680.3M
Q1 2021: $1.00KQ2 2021: $1.71BQ3 2021: $1.26BQ4 2021: $1.62BQ1 2022: $680.3MQ2 2022: $861.1MQ3 2022: $1.21BQ4 2022: $954.0MQ1 2023: $841.4MQ2 2023: $952.8MQ3 2023: $1.16BQ4 2023: $2.04BQ1 2024: $2.12BQ2 2024: $1.89BQ3 2024: $1.74BQ4 2024: $2.06BQ1 2025: $1.63BQ2 2025: $1.57BQ3 2025: $1.58BQ4 2025: $1.33BQ1 2026: $1.03BQ2 2026: $1.33B
Institutions holding RXRX and their total value by quarter
QuarterHoldersValue
Q2 2026344$1.33B
Q1 2026335$1.03B
Q4 2025335$1.33B
Q3 2025322$1.58B
Q2 2025333$1.57B
Q1 2025337$1.63B
Q4 2024316$2.06B
Q3 2024268$1.74B
Q2 2024270$1.89B
Q1 2024248$2.12B
Q4 2023199$2.04B
Q3 2023192$1.16B
Q2 2023158$952.8M
Q1 2023159$841.4M
Q4 2022144$954.0M
Q3 2022146$1.21B
Q2 2022133$861.1M
Q1 2022128$680.3M
Q4 2021126$1.62B
Q3 202184$1.26B
Q2 202175$1.71B
Q1 20211$1.00K

Institutions, Q1 2022

Shares, value and share of portfolio for each institution holding Recursion Pharmaceuticals, Inc.; share changes are against Q4 2021.

Institutions holding RXRX in Q1 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Tudor Investment Corp Et Al11,914$85.0K0.00%+11,914New
Arizona State Retirement System10,781$77.0K0.00%+81+0.8%Added
Assenagon Asset Management S.A.10,179$73.0K0.00%00.0%Unchanged
Wells Fargo & Company10,044$71.0K0.00%−40,601−80.2%Reduced
Resolute Partners Group9,168$66.0K0.00%00.0%Unchanged
Ameritas Investment Partners, Inc.8,908$64.0K0.00%00.0%Unchanged
Virtus ETF Advisers LLC8,321$60.0K0.03%−500−5.7%Reduced
Metropolitan Life Insurance Co7,689$55.1K0.00%−22,833−74.8%Reduced
Daiwa Securities Group Inc.7,241$52.0K0.00%+2,127+41.6%Added
Royal Bank of Canada7,081$51.0K0.00%−17,722−71.5%Reduced
UBS Group AG6,927$49.0K0.00%−252,295−97.3%Reduced
BDO Wealth Advisors, LLC6,082$44.0K0.00%00.0%Unchanged
Macquarie Group Ltd4,927$35.0K0.00%+4,927New
Signaturefd, LLC4,250$30.0K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.3,808$27.0K0.00%+633+19.9%Added
Tower Research Capital LLC (TRC)2,938$21.0K0.00%−1,171−28.5%Reduced
Itau Unibanco Holding S.A.2,530$18.0K0.00%00.0%Unchanged
Cutler Group LP1,140$8.00K0.00%00.0%Unchanged
Nisa Investment Advisors, LLC1,080$8.00K0.00%+1,080New
TCI Wealth Advisors, Inc.594$4.00K0.00%+379+176.3%Added
Simplex Trading, LLC397$2.00K0.00%−485−55.0%Reduced
Albion Financial Group120$1.00K0.00%−6,094−98.1%Reduced
Activest Wealth Management186$1.00K0.00%00.0%Unchanged
Private Capital Group, LLC196$1.00K0.00%+111+130.6%Added
Captrust Financial Advisors161$1.00K0.00%+141+705.0%Added
Tucker Asset Management LLC30$2150.00%+30New
Covestor Ltd25$00.00%−7−21.9%Reduced
Ellevest, Inc.19$00.00%+19New
PointState Capital LP0$00.00%−409,567−100.0%Sold out
Bamco Inc0$00.00%−408,563−100.0%Sold out
Sumitomo Mitsui Trust Holdings, Inc.0$00.00%−368,994−100.0%Sold out
Kemnay Advisory Services Inc.0$00.00%−121,573−100.0%Sold out
Mission Creek Capital Partners, Inc.0$00.00%−111,850−100.0%Sold out
Spouting Rock Asset Management, LLC0$00.00%−90,203−100.0%Sold out
StepStone Group LP0$00.00%−59,763−100.0%Sold out
Voya Investment Management LLC0$00.00%−42,851−100.0%Sold out
DekaBank Deutsche Girozentrale0$00.00%−35,000−100.0%Sold out
Russell Investments Group, Ltd.0$00.00%−34,166−100.0%Sold out
Seven Eight Capital, LP0$00.00%−26,001−100.0%Sold out
SG Americas Securities, LLC0$00.00%−22,842−100.0%Sold out
Zurcher Kantonalbank (Zurich Cantonalbank)0$00.00%−16,065−100.0%Sold out
Weiss Asset Management LP0$00.00%−15,880−100.0%Sold out
Trexquant Investment LP0$00.00%−12,050−100.0%Sold out
CWM, LLC0$00.00%−4,510−100.0%Sold out
Evoke Wealth, LLC0$00.00%−4,480−100.0%Sold out
Baldwin Brothers Inc0$00.00%−2,751−100.0%Sold out
Eaton Vance Management0$00.00%−200−100.0%Sold out
Parallel Advisors, LLC0$00.00%−151−100.0%Sold out
Northwestern Mutual Wealth Management Co0$00.00%−8−100.0%Sold out
Bell Investment Advisors, Inc––––Not filed